Dr. Reddy's Laboratories Limited - stock earnings

RDY Quarterly earnings

DateEarningsRevenue
2023Q4 165.6 million USD 866.7 million USD
2023Q3 178.2 million USD 828.6 million USD
2023Q2 171.1 million USD 822.0 million USD
2023Q1 116.8 million USD 766.5 million USD
2022Q4 150.9 million USD 819.1 million USD
2022Q3 136.5 million USD 773.5 million USD
2022Q2 150.5 million USD 660.9 million USD
2022Q1 11.6 million USD 718.2 million USD
2021Q4 94.8 million USD 714.1 million USD
2021Q3 133.6 million USD 776.3 million USD
2021Q2 76.7 million USD 661.4 million USD
2021Q1 75.6 million USD 645.9 million USD
2020Q4 2.7 million USD 674.6 million USD
2020Q3 103.7 million USD 665.9 million USD
2020Q2 76.7 million USD 584.7 million USD
2020Q1 101.4 million USD 588.3 million USD
2019Q4 -80.0 million USD 615.3 million USD
2019Q3 154.9 million USD 680.9 million USD
2019Q2 96.1 million USD 557.2 million USD
2019Q1 62.8 million USD 581.1 million USD
2018Q4 69.4 million USD 550.9 million USD
2018Q3 69.5 million USD 523.9 million USD
2018Q2 66.3 million USD 541.1 million USD
2018Q1 46.5 million USD 543.5 million USD
2017Q4 52.2 million USD 594.7 million USD
2017Q3 43.6 million USD 542.3 million USD
2017Q2 9.2 million USD 513.5 million USD
2017Q1 48.2 million USD 548.6 million USD
2016Q4 69.2 million USD 545.5 million USD
2016Q3 44.2 million USD 537.2 million USD
2016Q2 18.8 million USD 480.4 million USD
2016Q1 11.3 million USD 566.6 million USD
2015Q4 87.2 million USD 597.7 million USD
2015Q3 109.6 million USD 605.8 million USD
2015Q2 98.3 million USD 590.6 million USD
2015Q1 83.1 million USD 619.9 million USD
2014Q4 90.7 million USD 606.9 million USD
2014Q3 93.4 million USD 583.5 million USD
2014Q2 91.7 million USD 586.2 million USD
2014Q1 80.5 million USD 581.9 million USD
2013Q4 100.0 million USD 571.3 million USD
2013Q3 109.7 million USD 533.7 million USD
2013Q2 94.9 million USD 555.5 million USD
2013Q1 105.3 million USD 616.0 million USD
2012Q4 68.9 million USD 521.6 million USD
2012Q3 76.9 million USD 544.1 million USD
2012Q2 60.4 million USD 468.5 million USD
2012Q1 66.8 million USD 518.4 million USD
2011Q4 96.8 million USD 522.2 million USD
2011Q3 63.0 million USD 463.9 million USD
2011Q2 75.0 million USD 452.3 million USD
2011Q1 75.0 million USD 452.2 million USD
2010Q4 61.0 million USD 423.9 million USD
2010Q3 64.2 million USD 418.4 million USD
2010Q2 35.8 million USD 353.2 million USD
2010Q1 37.2 million USD 366.6 million USD
2009Q4 -112.4 million USD 372.7 million USD
2009Q3 45.4 million USD 384.1 million USD
2009Q2 -204.6 million USD 415.3 million USD
2009Q1 -192.4 million USD 390.7 million USD
2008Q4 50.4 million USD 379.3 million USD
2008Q3 22.6 million USD 346.6 million USD
2008Q2 23.9 million USD 308.5 million USD
2008Q1 25.7 million USD 331.4 million USD
2007Q4 -21.6 million USD 314.3 million USD
2007Q3 56.7 million USD 308.2 million USD
2007Q2 80.3 million USD 384.5 million USD
2007Q1 75.6 million USD 361.9 million USD
2006Q4 42.9 million USD 352.0 million USD
2006Q3 -5.1 million USD 153.1 million USD
2006Q2 30.6 million USD 308.0 million USD
2006Q1 -5.2 million USD 157.2 million USD
2005Q4 14.0 million USD 131.8 million USD
2005Q3 20.2 million USD 131.0 million USD
2005Q2 -10.6 million USD 125.3 million USD
2005Q1 -10.6 million USD 124.5 million USD
2004Q4 849623 USD 99.8 million USD
2004Q3 11.3 million USD 118.1 million USD
2004Q2 3.6 million USD 104.6 million USD
2004Q1 3.9 million USD 110.8 million USD
2003Q4 13.0 million USD 112.9 million USD
2003Q3 20.4 million USD 117.8 million USD
2003Q2 14.4 million USD 91.1 million USD
2003Q1 14.0 million USD 88.6 million USD
2002Q4 14.5 million USD 90.9 million USD
2002Q3 19.7 million USD 101.9 million USD
2002Q2 21.5 million USD 81.0 million USD
2002Q1 21.4 million USD 80.8 million USD
2001Q4 27.1 million USD 94.4 million USD
2001Q3 44.2 million USD 106.4 million USD
2001Q2 9.4 million USD 63.9 million USD
2001Q1 340740 USD 5.5 million USD
2000Q1 317251 USD 2.6 million USD

RDY Yearly earnings

DateEarningsRevenue
2023 548.6 million USD 3.0 billion USD
2022 311.3 million USD 2.8 billion USD
2021 235.5 million USD 2.6 billion USD
2020 258.8 million USD 2.3 billion USD
2019 271.9 million USD 2.2 billion USD
2018 150.8 million USD 2.2 billion USD
2017 185.8 million USD 2.2 billion USD
2016 301.9 million USD 2.3 billion USD
2015 355.2 million USD 2.4 billion USD
2014 359.6 million USD 2.2 billion USD
2013 309.4 million USD 2.1 billion USD
2012 278.1 million USD 1.9 billion USD
2011 247.5 million USD 1.7 billion USD
2010 23.8 million USD 1.6 billion USD
2009 -101.7 million USD 1.4 billion USD
2008 117.3 million USD 1.3 billion USD
2007 37.9 million USD 564.5 million USD
2006 291 USD 438277 USD
2005 4.8 million USD 445.2 million USD
2004 57.2 million USD 464.6 million USD
2003 74.0 million USD 378.3 million USD
2002 100.8 million USD 340.4 million USD
2001 15.9 million USD 235.3 million USD
2000 317251 USD 2.6 million USD

RDY

Price: 73.51USD

52 week price:
51.47
77.72

Dividend Yield: 0.67%

5-year range yield:
0.67%
1.56%

Forward Dividend Yield: 1.33%

Payout Ratio: 25.60%

Payout Ratio Range:
9.97%
83.90%

Dividend Per Share: 0.97 USD

Earnings Per Share: 3.77 USD

P/E Ratio: 19.58

Exchange: NYQ

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Volume: 129000

Ebitda: 142.4 million

Market Capitalization: 12.3 billion

Average Dividend Frequency: 1

Years Paying Dividends: 22

DGR3: 5.95%

DGR5: 5.95%

DGR10: 3.84%

Links: